Patients with heart failure undergoing cardiac surgery face a significantly increased perioperative risk, yet no standardized strategy exists to mitigate this risk effectively. Current preoperative management relies on optimization of medical therapy without a structured prehabilitation approach. Given the strong association between eleveated preoperative N-terminal pro-B-type natriuretic peptide levels and postoperative outcomes, patients at increased risk could be identified using this biomarker. Telemedical disease management programs have demonstrated efficacy in outpatient heart failure care, but their role in preoperative optimization remains underexplored. This study aims to assess whether a structured, multidisciplinary, telemedicine-assisted prehabilitation program can reduce perioperative complications, and improve surgical outcomes.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Hierachical Endpoint Perioperative Outcome: 30-day mortality
Timeframe: assessed from randomization through 30 days post-surgery,
Hierachical Endpoint Perioperative Outcome: ECMO
Timeframe: assessed from surgery until 30 days post-surgery
Hierachical Endpoint Perioperative Outcome: hemodialysis or ultrafiltration
Timeframe: assessed from surgery until 30 days post-surgery
Hierachical Endpoint Perioperative Outcome: stay on ICU
Timeframe: assessed from surgery until 30 days post-surgery.